EMCUREPharmaceuticals
Emcure Pharmaceuticals Ltd — PE Ratio & Valuation Analysis
₹1595.50
+4.14%
Current P/E33.89xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E45.0x24.7% below avg
⚠️
6.7% Premium to Industry
EMCURE P/E 33.89x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹36.43 | ₹1365 | 37.5x |
| 2024 | ₹27.57 | ₹1447 | 52.5x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Emcure Pharmaceuticals Ltd Valuation
Emcure Pharmaceuticals Ltd (EMCURE) currently trades at 33.89x earnings. The Pharmaceuticals sector average PE is 31.77x. EMCURE commands a premium, reflecting high growth expectations. Historically, EMCURE has traded at an average PE of 45.0x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
18.51%
Dividend Yield
0.21%
More on Emcure Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.